                         SEQUENCE LISTING

<110>  Deutsches Krebsforschungszentrum
       Ruprecht-Karls-Universitt
 
<120>  Norovirus antibodies

<130>  DK12914PC

<160>  12    

<170>  PatentIn version 3.3

<210>  1
<211>  7
<212>  PRT
<213>  Norovirus


<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  Xaa is any amino acid, preferably Q or P

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  Xaa is any amino acid, preferably T or S

<400>  1

Trp Val Asn Xaa Phe Tyr Xaa 
1               5           


<210>  2
<211>  12
<212>  PRT
<213>  Norovirus


<220>
<221>  VARIANT
<222>  (2)..(5)
<223>  Xaa is any amino acid

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  Xaa is any amino acid, preferably  Q or P

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  Xaa is any amino acid, preferably T or S

<400>  2

Phe Xaa Xaa Xaa Xaa Trp Val Asn Xaa Phe Tyr Xaa 
1               5                   10          


<210>  3
<211>  60
<212>  PRT
<213>  Norovirus


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa is a non-charged amino acid, preferably L, P, M, Q, or N

<220>
<221>  VARIANT
<222>  (2)..(53)
<223>  Xaa is a any amino acid

<220>
<221>  VARIANT
<222>  (57)..(57)
<223>  Xaa is any amino acid, preferably Q or P

<220>
<221>  VARIANT
<222>  (60)..(60)
<223>  Xaa is any amino acid, preferably, T or S

<400>  3

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  45              


Xaa Xaa Xaa Xaa Xaa Trp Val Asn Xaa Phe Tyr Xaa 
    50                  55                  60  


<210>  4
<211>  60
<212>  PRT
<213>  Norovirus


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa is a non-charged amino acid, preferably L, P, M, Q, or N

<220>
<221>  VARIANT
<222>  (2)..(53)
<223>  Xaa is a non-charged amino acid, preferably L, P, M, Q, or N

<220>
<221>  VARIANT
<222>  (2)..(48)
<223>  Xaa is any amino acid

<220>
<221>  VARIANT
<222>  (50)..(53)
<223>  Xaa is any amino acid

<220>
<221>  VARIANT
<222>  (57)..(57)
<223>  Xaa is any amino acid, preferably Q or P

<220>
<221>  VARIANT
<222>  (60)..(60)
<223>  Xaa is any amino acid, preferably T or S

<400>  4

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  45              


Phe Xaa Xaa Xaa Xaa Trp Val Asn Xaa Phe Tyr Xaa 
    50                  55                  60  


<210>  5
<211>  381
<212>  DNA
<213>  Artificial

<220>
<223>  synthetic sb-AB from Lama pacos

<400>  5
gatgtgcagc tggtggagtc tgggggaggc ttggtgcagc ctggggggtc tctgagactc     60

tcctgtgcag cctctggaag catcttcagt atctatgcca tgggctggta ccgccaggct    120

ccagggaagc agcgcgagtt ggtcgcttct attagtagtg gtggtggcac aaactatgca    180

gactccgtga agggccgatt caccatctcc ggagacaacg ccaagaacac ggtgtatctg    240

caaatgaaca gcctgaaacc tgaggacacg gccgtctatt actgtaaaag agaagactat    300

agcgcctatg cgcccccgag tggttcccgg ggccggggga cccaggtcac cgtctcctca    360

caccaccatc accatcacta a                                              381


<210>  6
<211>  8
<212>  PRT
<213>  Lama pacos

<400>  6

Gly Ser Ile Phe Ser Ile Tyr Ala 
1               5               


<210>  7
<211>  8
<212>  PRT
<213>  Lama pacos

<400>  7

Ile Ser Ser Gly Gly Gly Thr Asn 
1               5               


<210>  8
<211>  14
<212>  PRT
<213>  Lama pacos

<400>  8

Lys Arg Glu Asp Tyr Ser Ala Tyr Ala Pro Pro Ser Gly Ser 
1               5                   10                  


<210>  9
<211>  135
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic sb-AB from Lama pacos

<400>  9

Asp Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ser Ile Phe Ser Ile Tyr 
            20                  25                  30          


Ala Met Gly Trp Tyr Arg Gln Ala Pro Gly Lys Gln Arg Glu Leu Val 
        35                  40                  45              


Ala Ser Ile Ser Ser Gly Gly Gly Thr Asn Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Gly Asp Asn Ala Lys Asn Thr Val Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Val Tyr Tyr Cys Lys 
                85                  90                  95      


Arg Glu Asp Tyr Ser Ala Tyr Ala Pro Pro Ser Gly Ser Arg Gly Arg 
            100                 105                 110         


Gly Thr Gln Val Thr Val Ser Ser Gly Arg Tyr Pro Tyr Asp Val Pro 
        115                 120                 125             


Asp Tyr Gly Ser Gly Arg Ala 
    130                 135 


<210>  10
<211>  7
<212>  PRT
<213>  Norovirus

<400>  10

Trp Val Asn Gln Phe Tyr Thr 
1               5           


<210>  11
<211>  7
<212>  PRT
<213>  Norovirus

<400>  11

Trp Val Asn Gln Phe Tyr Ser 
1               5           


<210>  12
<211>  7
<212>  PRT
<213>  Norovirus

<400>  12

Trp Val Asn Pro Phe Tyr Thr 
1               5           


